Innate Pharma SA (NASDAQ:IPHA) appears in 10 institutional 13F filings for the quarter ending June 2026.
| # | Institution | CIK | Shares Held | % of Outstanding | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|---|---|
| 1 | Lion Point Capital, LP | 0001643354 | 81,151 | 0.09% | 0 | 0.00% | $149.32K |
| 2 | Morgan Stanley | 0000895421 | 43,524 | 0.05% | 0 | 0.00% | $80.08K |
| 3 | SmartHarvest Portfolios, LLC | 0002066604 | 23,750 | 0.03% | ▲23,750 | 0.00% | $43.70K |
| 4 | XTX Topco Ltd | 0001828301 | 15,130 | 0.02% | ▲15,130 | 0.00% | $27.84K |
| 5 | CITADEL ADVISORS LLC | 0001423053 | 12,441 | 0.01% | ▲12,441 | 0.00% | $22.89K |
| 6 | JANE STREET GROUP, LLC | 0001595888 | 10,310 | 0.01% | ▼33,055 | -76.23% | $18.97K |
| 7 | RHUMBLINE ADVISERS | 0001115418 | 4,719 | 0.01% | ▼15 | -0.32% | $8.68K |
| 8 | UBS Group AG | 0001610520 | 1,363 | 0.00% | ▲502 | +58.30% | $2.51K |
| 9 | Farther Finance Advisors, LLC | 0001992825 | 21 | 0.00% | ▲11 | +110.00% | $38 |
| 10 | GAMMA Investing LLC | 0002010235 | 9 | 0.00% | ▼231 | -96.25% | $17 |